Chemical Space Landscape Report
Every structure claimed across a large patent family, consolidated and counted.
Need this run on your own compound or patent? Landscape Report needs a hand-reviewed case build, not an automated minutes-long check: get a Standard Report with real human sign-off.
US12187755B2's patent family spans 44 publications, 823 unique structures found (71.4% family overlap)
DOCDB family landscape for US12187755B2 (Memorial Sloan Kettering Cancer Center, 'Minimal saponin analogues, synthesis and use thereof'). Consolidated across 44 family publications: 823 unique chemical structures claimed, with 588 (71.4%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
US12187741B2's patent family spans 37 publications, 838 unique structures found (82.9% family overlap)
DOCDB family landscape for US12187741B2 (Asceneuron SA, 'Glycosidase inhibitors'). Consolidated across 37 family publications: 838 unique chemical structures claimed, with 695 (82.9%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
US12187742B2's patent family spans 19 publications, 1285 unique structures found (0.0% family overlap)
DOCDB family landscape for US12187742B2 (XRad Therapeutics Inc, 'Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy'). Consolidated across 19 family publications: 1285 unique chemical structures claimed, with 0 (0.0%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
US12187724B2's patent family spans 94 publications, 1283 unique structures found (69.3% family overlap)
DOCDB family landscape for US12187724B2 (Chugai Pharmaceutical Co Ltd, 'Pyrazolopyridine derivative having GLP-1 receptor agonist effect'). Consolidated across 94 family publications: 1283 unique chemical structures claimed, with 889 (69.3%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
US12187702B2's patent family spans 19 publications, 932 unique structures found (54.8% family overlap)
DOCDB family landscape for US12187702B2 (Inflazome Ltd, 'Sulfonamideurea compounds'). Consolidated across 19 family publications: 932 unique chemical structures claimed, with 511 (54.8%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
US12187713B2's patent family spans 26 publications, 879 unique structures found (33.1% family overlap)
DOCDB family landscape for US12187713B2 (Betta Pharmaceuticals Co Ltd, 'Immunomodulators, compositions and methods thereof'). Consolidated across 26 family publications: 879 unique chemical structures claimed, with 291 (33.1%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
US12186313B2's patent family spans 66 publications, 804 unique structures found (80.1% family overlap)
DOCDB family landscape for US12186313B2 (Takeda Pharmaceutical Co Ltd, 'Pyridazinone compounds and their use as DAAO inhibitors'). Consolidated across 66 family publications: 804 unique chemical structures claimed, with 644 (80.1%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
US12187731B2's patent family spans 128 publications, 2547 unique structures found (65.3% family overlap)
DOCDB family landscape for US12187731B2 (Vertex Pharmaceuticals Inc, 'Compounds useful as inhibitors of ATR kinase'). Consolidated across 128 family publications: 2547 unique chemical structures claimed, with 1663 (65.3%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
US11274115B2's patent family spans 10 publications, 142 unique structures found (86.6% family overlap)
DOCDB family landscape for US11274115B2 (GlaxoSmithKline, 'Imidazoquinoline compounds and uses thereof'). Consolidated across 10 family publications: 142 unique chemical structures claimed, with 123 (86.6%) appearing in two or more family members. Direct structural consolidation maps claimed chemical density vs genuinely open design-around space.
Frequently asked
How are these samples made?
The patent family is fetched live, the structures in every member are extracted and consolidated, and the counts shown are the result of that run. Only families with at least 5 members and 50 unique structures are published here.